Product
Therapeutic Autologous Dendritic Cells
Aliases
therapeutic autologous dendritic cells
6 clinical trials
13 indications
Indication
Renal Cell CarcinomaIndication
Breast CancerIndication
Stage III Cutaneous Melanoma AJCC v7Indication
Stage IIIA Cutaneous Melanoma AJCC v7Indication
Cutaneous MelanomaIndication
Stage IV Cutaneous MelanomaIndication
Colorectal CancerIndication
Colorectal Cancer stage IV AJCC v8Indication
Hepatocellular CarcinomaIndication
Intrahepatic CholangiocarcinomaIndication
intrahepatic cholangiocarcinomaIndication
Brain NeoplasmsClinical trial
Vaccine Biotherapy Of Cancer: Autologous Tumor Cells And Dendritic Cells As Active Specific Immunotherapy In Patients With Stage IV Renal Cell CarcinomaStatus: Terminated, Estimated PCD: 2009-12-01
Clinical trial
Neoadjuvant Intratumoral Injection of Dendritic Cells in Breast Cancer Translation of Biotechnology Into the ClinicStatus: Completed, Estimated PCD: 2009-07-01
Clinical trial
Phase Ib/II Study of Autologous Dendritic Cell Therapy Delivered Intratumorally After Cryoablation in Combination With Pembrolizumab for Patients With Metastatic or Unresectable MelanomaStatus: Active (not recruiting), Estimated PCD: 2024-10-31
Clinical trial
A Phase 2 Study of Intravenous Pembrolizumab and Intratumorally Injected Autologous Dendritic Cells (DCs) in Refractory Colorectal Cancer (CRC)Status: Not yet recruiting, Estimated PCD: 2026-10-01
Clinical trial
Study of Intratumoral Injection of Dendritic Cells After High-Dose Conformal External Beam Radiotherapy in Patients With Unresectable Liver CancerStatus: Recruiting, Estimated PCD: 2027-08-31
Clinical trial
Anti-Tumor Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed Glioblastoma Multiforme During Recovery From Therapeutic Temozolomide-induced LymphopeniaStatus: Completed, Estimated PCD: 2017-04-15